10x Genomics Overview10x Genomics EBIT
EBIT (Earnings Before Interest and Taxes) analysis for TXG.
Quarterly EBIT
-$17.05M
↑ 56.66% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$31.83M
↑ 82.48% YoY
Trailing 12 months ending Mar 31, 2026
10x Genomics OverviewEBIT (Earnings Before Interest and Taxes) analysis for TXG.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026